Durham pharma scores FDA, CE approvals; readies for product launch

BioM érieux, with a fresh FDA and CE clearance, is launching a new product it hopes will lower infection rates and deaths for blood transfusion patients.  The Durham-based company, which focuses on in-vitro diagnostic testing, has announced the U.S. Food and Drug Administration clearance of its BPA an d BPN culture bottles. The new test was researched and developed at the company's Durham facility. It aims to reduce blood platelet shortages and deaths from contaminated blood.  The culture bottles…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news